Header Logo

Connection

Ali Keshavarzian to Parkinson Disease

Back to Details
This is a "connection" page, showing publications Ali Keshavarzian has written about Parkinson Disease.
Ali Keshavarzian
Connection Strength
4.355
Parkinson Disease
  1. Overview of the Gut-Brain Axis: From Gut to Brain and Back Again. Semin Neurol. 2023 08; 43(4):506-517.
    View in: PubMed
    Score: 0.525
  2. An open label, non-randomized study assessing a prebiotic fiber intervention in a small cohort of Parkinson's disease participants. Nat Commun. 2023 02 18; 14(1):926.
    View in: PubMed
    Score: 0.508
  3. Intestinal microbiota and neuroinflammation in Parkinson's disease: At the helm of the gut-brain axis. Int Rev Neurobiol. 2022; 167:81-99.
    View in: PubMed
    Score: 0.492
  4. Gut microbial metabolites in Parkinson's disease: Association with lifestyle, disease characteristics, and treatment status. Neurobiol Dis. 2022 08; 170:105780.
    View in: PubMed
    Score: 0.483
  5. The gut microbiome in Parkinson's disease: A culprit or a bystander? Prog Brain Res. 2020; 252:357-450.
    View in: PubMed
    Score: 0.414
  6. Role of TLR4 in the gut-brain axis in Parkinson's disease: a translational study from men to mice. Gut. 2019 05; 68(5):829-843.
    View in: PubMed
    Score: 0.381
  7. Colonic bacterial composition in Parkinson's disease. Mov Disord. 2015 Sep; 30(10):1351-60.
    View in: PubMed
    Score: 0.300
  8. Increased intestinal permeability correlates with sigmoid mucosa alpha-synuclein staining and endotoxin exposure markers in early Parkinson's disease. PLoS One. 2011; 6(12):e28032.
    View in: PubMed
    Score: 0.234
  9. Integrated Multi-Cohort Analysis of the Parkinson's Disease Gut Metagenome. Mov Disord. 2023 03; 38(3):399-409.
    View in: PubMed
    Score: 0.126
  10. A prebiotic diet modulates microglial states and motor deficits in a-synuclein overexpressing mice. Elife. 2022 11 08; 11.
    View in: PubMed
    Score: 0.125
  11. Experimental colitis promotes sustained, sex-dependent, T-cell-associated neuroinflammation and parkinsonian neuropathology. Acta Neuropathol Commun. 2021 08 19; 9(1):139.
    View in: PubMed
    Score: 0.115
  12. Gut bacterial tyrosine decarboxylases restrict levels of levodopa in the treatment of Parkinson's disease. Nat Commun. 2019 01 18; 10(1):310.
    View in: PubMed
    Score: 0.096
  13. Gut bacterial composition in a mouse model of Parkinson's disease. Benef Microbes. 2018 Sep 18; 9(5):799-814.
    View in: PubMed
    Score: 0.093
  14. The gut-brain axis in Parkinson's disease: Possibilities for food-based therapies. Eur J Pharmacol. 2017 Dec 15; 817:86-95.
    View in: PubMed
    Score: 0.085
  15. Gut-brain and brain-gut axis in Parkinson's disease models: Effects of a uridine and fish oil diet. Nutr Neurosci. 2018 Jul; 21(6):391-402.
    View in: PubMed
    Score: 0.084
  16. Gut Microbiota Regulate Motor Deficits and Neuroinflammation in a Model of Parkinson's Disease. Cell. 2016 Dec 01; 167(6):1469-1480.e12.
    View in: PubMed
    Score: 0.083
  17. Progression of intestinal permeability changes and alpha-synuclein expression in a mouse model of Parkinson's disease. Mov Disord. 2014 Jul; 29(8):999-1009.
    View in: PubMed
    Score: 0.067
  18. Is alpha-synuclein in the colon a biomarker for premotor Parkinson's disease? Evidence from 3 cases. Mov Disord. 2012 May; 27(6):716-9.
    View in: PubMed
    Score: 0.060
  19. Alpha-synuclein in colonic submucosa in early untreated Parkinson's disease. Mov Disord. 2012 May; 27(6):709-15.
    View in: PubMed
    Score: 0.057
  20. Gut bacterial deamination of residual levodopa medication for Parkinson's disease. BMC Biol. 2020 10 20; 18(1):137.
    View in: PubMed
    Score: 0.027
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.